New Hope for the Patients of Hepatitis C in Pakistan

New Hope for the Patients of Hepatitis C in Pakistan |

New Hope for the Patients of Hepatitis C in Pakistan |

ISLAMABAD – After awarding registration in Pakistan, The Drug Regulatory Authority of Pakistan (DRAP) has set the price of life saving medicine of Hepatitis C named as Sovaldi.

The decision was taken after Ministry of Health gave the license to a private company Ferozsons laboratories, the sole company which was granted rights to sell and market this much-awaited drug in Pakistan at a price approximately Rs1,940 for each tablet.

The company will make available a pack of 28 tablets for total price Rs 55, 000 after final approval by the federal government.
American pharmaceutical company, Gilead Science, had produced this miracle drug in oral form last year for the treatment of chronic hepatitis C.

The drug Sovaldi is available in the US market for 1000 dollar for each tablet for the patients belonging to the elite class only.
It was later introduced in the international market and because of tremendously high demand of the oral drug, the company announced that the drug would be made available in the low-income countries on discounted price.

Do you have information you wish to share with PakistanTribeCom? Email our News Desk to share news tips, reports and general feedback. You can also email the Blog Desk if you have an opinion or narrative to share. Follow PakistanTribe on Twitter and Join us on Facebook

About the author

Ummer Faizan

Ummer Faizan is currently working as a Web Producer at Pakistan Tribe's Islamabad Office. He is the Mass Communication undergrad and holds keen interest in analyzing current state of affairs with the perspective of Pakistani youth.

Add Comment

Click here to post a comment


Subscribe PakistanTribe’s YouTube Channel